Regulation of CD23 expression by Notch2 in B-cell chronic lymphocytic leukemia (Q28300257)

B-cell chronic lymphocytic leukemia

Europe PubMed Central

title

Regulation of CD23 expression by Notch2 in B-cell chronic lymphocytic leukemia (English)

0 references

0 references

1 reference

1 reference

J D Schwarzmeier

1

0 references

R Hubmann

2

0 references

M Düchler

3

0 references

U Jäger

4

0 references

M Shehata

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

5

0 references

language of work or name

English

0 references

publication date

February 2005

0 references

published in

Leukemia & Lymphoma

0 references

volume

46

0 references

issue

2

0 references

page(s)

157-65

0 references

cites work

1 reference

https://api.crossref.org/works/10.1080/10428190400010742

Notch2 is involved in the overexpression of CD23 in B-cell chronic lymphocytic leukemia

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/10428190400010742

Notch signaling: cell fate control and signal integration in development

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/10428190400010742

Notch-RBP-J signaling is involved in cell fate determination of marginal zone B cells

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/10428190400010742

TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/10428190400010742

B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor

21 April 2017

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010742

ZAP-70 expression and prognosis in chronic lymphocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010742

Serum levels of soluble CD23, but not soluble CD25, predict disease progression in early stage B-cell chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010742

The clinical and diagnostic relevance of CD23 expression in the chronic lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010742

CD23/Fc epsilon RII: signaling and clinical implication

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010742

Association of CD38 antigen expression with other prognostic parameters in early stages of chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010742

Identification of antigenic determinants unique to the surfaces of cells transformed by Epstein–Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010742

Fc epsilon receptor, a specific differentiation marker transiently expressed on mature B cells before isotype switching

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010742

CD23 (the low-affinity IgE receptor) as a C-type lectin: a multidomain and multifunctional molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010742

Heterogeneous expression of CD23 epitopes by eosinophils from patients. Relationships with IgE-mediated functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010742

Possible role of CD23 in allergic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010742

Low-affinity IgE receptor (CD23) function on mouse B cells: role in IgE-dependent antigen focusing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010742

Endocytosis and recycling of the complex between CD23 and HLA-DR in human B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010742

CD21 is a ligand for CD23 and regulates IgE production

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010742

IgE secretion is attenuated by an inhibitor of proteolytic processing of CD23 (Fc epsilonRII).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010742

CD23 (FcepsilonRII) release from cell membranes is mediated by a membrane-bound metalloprotease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010742

The low-affinity receptor for IgE

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010742

The Fc epsilon RII/CD23 gene is actively transcribed during all stages of murine B-lymphocyte development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010742

Two forms of the low-affinity Fc receptor for IgE differentially mediate endocytosis and phagocytosis: identification of the critical cytoplasmic domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010742

CD23 antigen regulation and signaling in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010742

Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010742

Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010742

Notch-1 and Notch-2 exhibit unique patterns of expression in human B-lineage cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010742

Activated Notch2 potentiates CD8 lineage maturation and promotes the selective development of B1 B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010742

Notch2 haploinsufficiency results in diminished B1 B cells and a severe reduction in marginal zone B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010742

Regulation of marginal zone B cell development by MINT, a suppressor of Notch/RBP-J signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010742

Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010742

Development and function of B-1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010742

Notch regulation of lymphocyte development and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010742

Cellular origin of human B-cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010742

Peripheral development of B cells in mouse and man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010742

Chronic lymphocytic leukemia: revelations from the B-cell receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010742

Notch oncoproteins depend on gamma-secretase/presenilin activity for processing and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010742

Two species of human Fc epsilon receptor II (Fc epsilon RII/CD23): tissue-specific and IL-4-specific regulation of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010742

Prognostic relevance of a scoring system based on clinical and biological parameters in early chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010742

Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010742